Anti-Inflammatory Diet in BRC Patients on Aromatase Inhibitors
Anti-Inflammatory Dietary Intervention in Breast Cancer Patients Receiving Aromatase Inhibitors
University of Belgrade
90 participants
Mar 1, 2024
INTERVENTIONAL
Conditions
Summary
This project aims to decrease undesirable side effects and increase qulaity of life of aromatase inhibitors therapy in breast cancer survivors, by anti-inflammatory diet or supplementation.
Eligibility
Plain Language Summary
Simplified for easier understanding
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Supplements of anti-inflammatory oils rich in omega-3 and gamma-linolenic acid
diet rich in whole grains, healthy oils and polyphenols,
Placebo caps with standard diet
Locations(2)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06214598